2023 Q1 Form 10-K Financial Statement

#000117891323000707 Filed on February 22, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $943.9M $890.7M $3.110B
YoY Change 44.09% 61.38% 58.38%
Cost Of Revenue $643.8M $629.7M $2.266B
YoY Change 35.21% 60.86% 69.77%
Gross Profit $300.1M $261.0M $844.6M
YoY Change 67.71% 62.66% 34.22%
Gross Profit Margin 31.8% 29.31% 27.16%
Selling, General & Admin $77.53M $72.68M $272.2M
YoY Change 25.57% 31.83% 35.28%
% of Gross Profit 25.83% 27.84% 32.22%
Research & Development $79.87M $78.96M $289.8M
YoY Change 20.38% 22.75% 31.95%
% of Gross Profit 26.61% 30.25% 34.31%
Depreciation & Amortization $13.46M $12.36M $40.58M
YoY Change 15.47% 17.13% 38.22%
% of Gross Profit 4.49% 4.74% 4.8%
Operating Expenses $156.0M $237.8M $678.5M
YoY Change 21.76% 99.1% 60.72%
Operating Profit $144.2M $23.21M $166.1M
YoY Change 183.41% -43.43% -19.8%
Interest Expense $23.67M $56.10M $13.54M
YoY Change -534.47% -987.11% 112.33%
% of Operating Profit 16.42% 241.67% 8.15%
Other Income/Expense, Net -$125.0K $186.0K $3.316M
YoY Change -116.65%
Pretax Income $167.7M $51.12M $177.2M
YoY Change 269.27% 47.27% -5.38%
Income Tax $29.33M $30.30M $83.38M
% Of Pretax Income 17.49% 59.26% 47.06%
Net Earnings $138.4M $20.83M $93.78M
YoY Change 317.77% -49.14% -44.57%
Net Earnings / Revenue 14.66% 2.34% 3.02%
Basic Earnings Per Share $2.46 $1.70
Diluted Earnings Per Share $2.46 $0.35 $1.65
COMMON SHARES
Basic Shares Outstanding 56.15M shares 55.89M shares 55.09M shares
Diluted Shares Outstanding 59.19M shares 58.10M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.139B $1.024B $1.024B
YoY Change -1.95% 46.78% 46.78%
Cash & Equivalents $727.8M $783.1M $783.1M
Short-Term Investments $410.8M $241.1M $241.1M
Other Short-Term Assets $259.6M $241.1M $37.82M
YoY Change 35.47% 36.21% -78.63%
Inventory $874.2M $729.2M $729.2M
Prepaid Expenses $9.233M
Receivables $969.5M $905.1M $905.1M
Other Receivables $0.00 $0.00 $203.3M
Total Short-Term Assets $3.242B $2.900B $2.900B
YoY Change 31.67% 69.44% 69.44%
LONG-TERM ASSETS
Property, Plant & Equipment $625.8M $544.0M $606.7M
YoY Change 17.36% 32.55% 32.61%
Goodwill $29.93M $31.19M
YoY Change -75.94%
Intangibles $17.93M $19.93M
YoY Change -66.14%
Long-Term Investments $509.1M $645.5M $645.5M
YoY Change 13.22% 33.86% 33.86%
Other Assets $71.52M $18.81M $62.96M
YoY Change 30.54% -44.45% 2.49%
Total Long-Term Assets $1.254B $1.366B $1.366B
YoY Change 2.77% 14.85% 14.85%
TOTAL ASSETS
Total Short-Term Assets $3.242B $2.900B $2.900B
Total Long-Term Assets $1.254B $1.366B $1.366B
Total Assets $4.496B $4.266B $4.266B
YoY Change 22.09% 47.05% 47.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $408.5M $459.8M $459.8M
YoY Change 69.07% 82.42% 82.42%
Accrued Expenses $334.7M $117.6M $291.5M
YoY Change 52.67% 105.81% 58.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.263M
YoY Change
Total Short-Term Liabilities $900.0M $889.7M $889.7M
YoY Change 58.25% 69.41% 69.41%
LONG-TERM LIABILITIES
Long-Term Debt $668.9M $669.8M $669.8M
YoY Change -1.0% 1.18% 1.18%
Other Long-Term Liabilities $576.7M $15.76M $530.0M
YoY Change 34.75% -19.37% 31.3%
Total Long-Term Liabilities $1.246B $1.200B $1.200B
YoY Change 12.86% 12.59% 12.59%
TOTAL LIABILITIES
Total Short-Term Liabilities $900.0M $889.7M $889.7M
Total Long-Term Liabilities $1.246B $1.200B $1.200B
Total Liabilities $2.146B $2.090B $2.090B
YoY Change 28.3% 31.34% 31.34%
SHAREHOLDERS EQUITY
Retained Earnings $882.2M $743.8M
YoY Change 14.43%
Common Stock $6.000K $6.000K
YoY Change 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.351B $2.176B $2.176B
YoY Change
Total Liabilities & Shareholders Equity $4.496B $4.266B $4.266B
YoY Change 22.09% 47.05% 47.05%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $138.4M $20.83M $93.78M
YoY Change 317.77% -49.14% -44.57%
Depreciation, Depletion And Amortization $13.46M $12.36M $40.58M
YoY Change 15.47% 17.13% 38.22%
Cash From Operating Activities $7.923M $111.3M $31.28M
YoY Change -104.86% 24.25% -85.39%
INVESTING ACTIVITIES
Capital Expenditures $38.34M $44.26M $169.3M
YoY Change -188.72% -184.91% 13.46%
Acquisitions $0.00
YoY Change
Other Investing Activities -$3.440M $7.726M -$4.138M
YoY Change -112.25% -122.64% -304.65%
Cash From Investing Activities -$67.78M -$36.53M -$417.0M
YoY Change 347.87% -57.65% -13.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$5.222M 7.472M $654.6M
YoY Change -100.8% 75.65% -4412.87%
NET CHANGE
Cash From Operating Activities $7.923M 111.3M $31.28M
Cash From Investing Activities -$67.78M -36.53M -$417.0M
Cash From Financing Activities -$5.222M 7.472M $654.6M
Net Change In Cash -$65.08M 82.24M $268.8M
YoY Change -113.72% 985.13% -194.25%
FREE CASH FLOW
Cash From Operating Activities $7.923M $111.3M $31.28M
Capital Expenditures $38.34M $44.26M $169.3M
Free Cash Flow -$30.42M $67.04M -$138.1M
YoY Change -74.61% -52.68% -312.79%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-116538000 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9096000 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
10176000 usd
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9479000 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2916000 usd
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2903000 usd
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3185000 usd
CY2022 sedg Amortization Of Marketable Securities Premium Accretion
AmortizationOfMarketableSecuritiesPremiumAccretion
9310000 usd
CY2021 sedg Amortization Of Marketable Securities Premium Accretion
AmortizationOfMarketableSecuritiesPremiumAccretion
9462000 usd
CY2020 sedg Amortization Of Marketable Securities Premium Accretion
AmortizationOfMarketableSecuritiesPremiumAccretion
1168000 usd
CY2022 sedg Exchange Rate Fluctuations Net And Other Items
ExchangeRateFluctuationsNetAndOtherItems
10052000 usd
CY2021 sedg Exchange Rate Fluctuations Net And Other Items
ExchangeRateFluctuationsNetAndOtherItems
20697000 usd
CY2020 sedg Exchange Rate Fluctuations Net And Other Items
ExchangeRateFluctuationsNetAndOtherItems
3860000 usd
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
98673000 usd
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
3344000 usd
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
11630000 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
530089000 usd
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
827146000 usd
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
223901000 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4030000 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
6486000 usd
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
16671000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2021 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 usd
CY2020 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
617869000 usd
CY2022 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 usd
CY2020 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
16944000 usd
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
827146000 usd
CY2021 us-gaap Severance Costs1
SeveranceCosts1
14231000 usd
CY2020 us-gaap Severance Costs1
SeveranceCosts1
10598000 usd
CY2022Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
503257000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
247386000 usd
CY2022Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
23407000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
13863000 usd
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
202537000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
118894000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
729201000 usd
CY2021Q4 sedg Government Authorities Receivable Current
GovernmentAuthoritiesReceivableCurrent
63440000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
4083000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
16330000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
3298000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
14746000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
3369000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7338000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
3539000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
4246000 usd
CY2022Q4 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
3539000 usd
CY2022Q4 sedg Provision For Legal Claims
ProvisionForLegalClaims
43000 usd
CY2021Q4 sedg Provision For Legal Claims
ProvisionForLegalClaims
11622000 usd
CY2022Q4 sedg Deferred Tax Assets Net1
DeferredTaxAssetsNet1
44153000 usd
CY2021Q4 sedg Deferred Tax Assets Net1
DeferredTaxAssetsNet1
27572000 usd
CY2022 sedg Effective Income Tax Rate Reconciliation Disallowable And Allowable Deductions
EffectiveIncomeTaxRateReconciliationDisallowableAndAllowableDeductions
0.132 pure
CY2021 sedg Effective Income Tax Rate Reconciliation Disallowable And Allowable Deductions
EffectiveIncomeTaxRateReconciliationDisallowableAndAllowableDeductions
0.02 pure
CY2022 sedg Expenses Income Net Related To Hedging Transactions
ExpensesIncomeNetRelatedToHedgingTransactions
-4716000 usd
CY2021 sedg Expenses Income Net Related To Hedging Transactions
ExpensesIncomeNetRelatedToHedgingTransactions
-9417000 usd
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1350000 usd
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3429000 usd
CY2022 us-gaap Other Income
OtherIncome
7719000 usd
CY2021 us-gaap Other Income
OtherIncome
0 usd
CY2020 us-gaap Other Income
OtherIncome
0 usd
CY2020 sedg Equity Component Of Convertible Senior Notes Net
EquityComponentOfConvertibleSeniorNotesNet
36336000 usd
CY2021 sedg Cumulative Effect Of Adopting Asc606
CumulativeEffectOfAdoptingAsc606
-33452000 usd
CY2022 sedg Underwriters Discounts And Commissions
UnderwritersDiscountsAndCommissions
27140000 usd
CY2022 sedg Offering Costs
OfferingCosts
834000 usd
CY2022 us-gaap Depreciation
Depreciation
40580000 usd
CY2021 us-gaap Depreciation
Depreciation
29359000 usd
CY2020 us-gaap Depreciation
Depreciation
22355000 usd
CY2022 sedg Gain From Sale Of Privately Held Company
GainFromSaleOfPrivatelyHeldCompany
7719000 usd
CY2021 sedg Gain From Sale Of Privately Held Company
GainFromSaleOfPrivatelyHeldCompany
0 usd
CY2020 sedg Gain From Sale Of Privately Held Company
GainFromSaleOfPrivatelyHeldCompany
0 usd
CY2022 sedg Proceeds From Sale Of A Privately Held Company
ProceedsFromSaleOfAPrivatelyHeldCompany
24362000 usd
CY2021 sedg Proceeds From Sale Of A Privately Held Company
ProceedsFromSaleOfAPrivatelyHeldCompany
0 usd
CY2020 sedg Proceeds From Sale Of A Privately Held Company
ProceedsFromSaleOfAPrivatelyHeldCompany
0 usd
CY2022 sedg Withdrawal From Investment Restricted Bank
WithdrawalFromInvestmentRestrictedBank
242000 usd
CY2021 sedg Withdrawal From Investment Restricted Bank
WithdrawalFromInvestmentRestrictedBank
-798000 usd
CY2020 sedg Withdrawal From Investment Restricted Bank
WithdrawalFromInvestmentRestrictedBank
-25267000 usd
CY2021 us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
0 usd
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-15824000 usd
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-11797000 usd
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-23257000 usd
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
783112000 usd
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
530089000 usd
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">b.<span style="padding-left:8.6pt">Use of estimates:</span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, costs and expenses and related disclosures in the accompanying notes. The duration, scope and effects of the ongoing Covid-19 pandemic and the conflict in Ukraine, government and other third-party responses to it, and the related macroeconomic effects, including to the Company’s business and the business of the Company’s suppliers and customers are uncertain, rapidly changing and difficult to predict. As a result, the Company’s accounting estimates and assumptions may change over time in response to this evolving situation. Such changes could result in future impairments of goodwill, intangibles, long-lived assets, inventories, incremental credit losses on receivables and available-for-sale marketable debt securities, or an increase in the Company’s insurance liabilities as of the time of a relevant measurement event.</span></span></div>
CY2022 us-gaap Financing Receivable Allowance For Credit Losses Write Offs
FinancingReceivableAllowanceForCreditLossesWriteOffs
103000 usd
CY2022Q4 sedg Reduction Of Fixed Assets
ReductionOfFixedAssets
7359000 usd
CY2022 us-gaap Derivatives Methods Of Accounting Hedging Derivatives
DerivativesMethodsOfAccountingHedgingDerivatives
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:0pt;text-indent:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">t.<span style="padding-left:8.6pt">Derivatives and Hedging:</span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company accounts for derivatives and hedging based on ASC 815 (“Derivatives and Hedging”). ASC 815 requires the Company to recognize all derivatives on the balance sheet at fair value. The accounting for changes in the fair value (i.e., gains or losses) of a derivative instrument depends on whether it has been designated and qualifies as part of a hedging relationship and further, on the type of hedging relationship.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">To protect against the increase in value of forecasted foreign currency cash flows resulting from salary denominated in the Israeli currency, the New Israeli Shekels (“NIS”), during the year ended December 31, 2022, the Company instituted a foreign currency cash flow hedging program whereby portions of the anticipated payroll denominated in NIS for a period of one to nine months with hedging contracts.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:11pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Accordingly, when the dollar strengthens against the NIS, the decline in present value of future foreign currency expenses is offset by losses in the fair value of the hedging contracts. Conversely, when the dollar weakens, the increase in the present value of future foreign currency cash flows is offset by gains in the fair value of the hedging contracts. These hedging contracts are designated as cash flow hedges, as defined by ASC 815 and are all effective hedges.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0pt;padding-left:0pt;margin-bottom:10pt"> <div/> <p style="margin:0pt"><span style="font-size:10pt">The Company al</span><span style="font-size:10pt">so entered into derivative instrument arrangements to hedge the Company’s exposure to currencies other than the U.S. dollar. These derivative instruments are not designated as cash flow hedges, as defined by ASC 815, and therefore all gains and losses, resulting from fair value remeasurement, were recorded immediately in the statement of income, as a financial income (expense), net..</span></p> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:10pt"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company classifies cash flows related to its hedging as operating activities in its consolidated statement of cash flows.</span></span></p> </div> </div>
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <div> <div> <div> <div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">aa.<span style="padding-left:8.6pt">Concentrations of credit risks:</span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, short-term bank deposits, restricted bank deposits, marketable securities, trade receivables, derivative instruments and other accounts receivable.</span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>Cash and cash equivalents, short-term bank deposits and restricted bank deposits are mainly invested in major banks in the U.S., Israel, Germany and Korea. Management believes that the financial institutions that hold the Company’s investments are financially sound and, accordingly, minimal credit risk exists with respect to these investments.</span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span><span><span style="color:black">The Company's debt marketable securities include investments in highly-rated corporate debentures (located mainly in U.S., Canada, France, UK, Cayman Islands and other countries) and governmental bonds</span></span></span><span><span>. The financial institutions that hold the Company's debt marketable securities are major financial institutions located in the United States. The Company believes its debt marketable securities portfolio is a diverse portfolio of highly-rated securities and the Company's investment policy limits the amount the Company may invest in an issuer (see Note 2g.).</span></span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-family:Times New Roman,Times,serif"><span style="font-size:10pt"><span><span>The trade receivables of the Company derive from sales to customers located primarily in the United States and Europe.</span></span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company performs ongoing credit evaluations of its customers for the purpose of determining the appropriate allowance for credit losses (see Note 2i.). The Company generally does not require collaterals, however, in certain circumstances, the Company may require letters of credit, other collateral, or additional guarantees. From time to time, the Company may purchase trade credit insurance.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"> <div/> </div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:0px;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company had one major customer (customers with attributable revenues that represents more than 10% of total revenues) for the year ended December 31, 2022, two major customers for the year ended December 31, 2021, and one major customer for the year ended December 31, 2020 that accounted for approximately 18.5%, 30.9%% and 14.8% of the Company’s consolidated revenues, respectively. All of the revenues from these customers were generated in the solar segment.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"> <p style="font-size:10pt;font-family:Times New Roman, Times, serif;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company had three major customers (customer with a balance that represents more than 10% of total trade receivables, net) as of December 31, 2022 and two major customers for the year ended December 31, 2021 that accounted in the aggregate for approximately 42.2% and 39.3%, of the Company’s consolidated trade receivables, net, respectively.</span></span></p> </div> </div> </div> </div> </div> </div>
CY2022 sedg Concentrations Of Supply Risks
ConcentrationsOfSupplyRisks
<div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:left;margin-top:12pt;text-indent:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">ab.<span style="padding-left:8.6pt">Concentrations of supply risks:</span></span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:0pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company depends on two contract manufacturers and several limited or single source component suppliers, including, Samsung SDI, that provides lithium-ion battery cells required for the Company's residential storage solution. Reliance on these vendors makes the Company vulnerable to possible capacity constraints and reduced control over component availability, delivery schedules, manufacturing yields, and costs. </span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;text-align:justify;margin-top:11pt;padding-left:0pt;margin-bottom:10pt"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">As of December 31, 2022 and 2021, two contract manufacturers collectively accounted for 34.3% and 27.9% of the Company’s total trade payables, net, respectively.</span></span></div> <div style="font-family:Times New Roman, Times, serif;font-size:10pt;margin-top:11pt;text-indent:0px;margin-bottom:0pt;margin-left:0pt;text-align:justify"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">In the second quarter of 2022, the Company announced the opening of “Sella 2”, a two gigawatt-hour (GWh) Li-Ion battery cell manufacturing facility located in South Korea. Sella 2 is in the ramp-up phase, that is expected to continue throughout  2023. Sella 2 is the Company's second owned manufacturing facility following the establishment of Sella 1 in 2020. Sella 1 is the Company's manufacturing facility in the North of Israel that produces power optimizers and inverters for the Company's solar activities.</span></span></div> </div>
CY2021Q4 us-gaap Inventory Net
InventoryNet
380143000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
3285000 usd
CY2020Q4 us-gaap Goodwill
Goodwill
140479000 usd
CY2022 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-8336000 usd
CY2022Q4 us-gaap Goodwill Impaired Accumulated Impairment Loss
GoodwillImpairedAccumulatedImpairmentLoss
90104000 usd
CY2022Q4 us-gaap Derivative Assets
DerivativeAssets
0 usd
CY2021Q4 us-gaap Derivative Assets
DerivativeAssets
4009000 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
1874000 usd
CY2021Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
169000 usd
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
214112000 usd
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
109379000 usd
CY2022 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2916000 usd
CY2021 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2903000 usd
CY2020 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
3185000 usd
CY2022Q4 sedg Other Noncurrent Liabilities
OtherNoncurrentLiabilities
2078000 usd
CY2021Q4 sedg Other Noncurrent Liabilities
OtherNoncurrentLiabilities
3805000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
10000000 shares
CY2022 sedg Capitalized Stock Based Compensation
CapitalizedStockBasedCompensation
380000 usd
CY2020 sedg Other Comprehensive Income Loss Reclassifications Tax On Revaluation
OtherComprehensiveIncomeLossReclassificationsTaxOnRevaluation
-204000 usd
CY2021 us-gaap Reclassification From Accumulated Other Comprehensive Income Current Period Net Of Tax
ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax
-2427000 usd
CY2022 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
-90104000 usd
CY2021 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2020 us-gaap Goodwill And Intangible Asset Impairment
GoodwillAndIntangibleAssetImpairment
0 usd
CY2022 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
-29037000 usd
CY2021 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
-2209000 usd
CY2020 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
-1471000 usd
CY2022 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-2603000 usd
CY2021 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 usd
CY2020 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0 usd
CY2022 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-116538000 usd
CY2021 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1350000 usd
CY2020 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
3429000 usd
CY2020 sedg Effective Income Tax Rate Reconciliation Disallowable And Allowable Deductions
EffectiveIncomeTaxRateReconciliationDisallowableAndAllowableDeductions
-0.026 pure
CY2022 sedg Effective Income Tax Rate Reconciliation Annual Revenue
EffectiveIncomeTaxRateReconciliationAnnualRevenue
10000000000 ils
CY2020 sedg Expenses Income Net Related To Hedging Transactions
ExpensesIncomeNetRelatedToHedgingTransactions
4013000 usd
CY2022 sedg Disposal Of Assets Related To Critical Power
DisposalOfAssetsRelatedToCriticalPower
-4314000 usd
CY2021 sedg Disposal Of Assets Related To Critical Power
DisposalOfAssetsRelatedToCriticalPower
0 usd
CY2020 sedg Disposal Of Assets Related To Critical Power
DisposalOfAssetsRelatedToCriticalPower
0 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001178913-23-000707-index-headers.html Edgar Link pending
0001178913-23-000707-index.html Edgar Link pending
0001178913-23-000707.txt Edgar Link pending
0001178913-23-000707-xbrl.zip Edgar Link pending
exhibit_10-11.htm Edgar Link pending
exhibit_21-1.htm Edgar Link pending
exhibit_23-1.htm Edgar Link pending
exhibit_3-3.htm Edgar Link pending
exhibit_31-1.htm Edgar Link pending
exhibit_31-2.htm Edgar Link pending
exhibit_32-1.htm Edgar Link pending
exhibit_32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R107.htm Edgar Link pending
R108.htm Edgar Link pending
R109.htm Edgar Link pending
R11.htm Edgar Link pending
R110.htm Edgar Link pending
R111.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
sedg-20221231.xsd Edgar Link pending
Show.js Edgar Link pending
zk2329263.htm Edgar Link pending
sedg-20221231_cal.xml Edgar Link unprocessable
sedg-20221231_def.xml Edgar Link unprocessable
sedg-20221231_pre.xml Edgar Link unprocessable
sedg-20221231_lab.xml Edgar Link unprocessable
zk2329263_htm.xml Edgar Link completed